Target's downtrend is mainly due to recent overbuying that prompted profit-taking but does not signal a bearish reversal.

VersaBank (NASDAQ:VBNK) outlined its approach to digital assets and tokenized banking services during a presentation at OTC ...

Tevogen Bio, the company’s lead initiative, has completed a proof-of-concept clinical trial demonstrating the potential of its single-HLA-restricted, genetically unmodified allogeneic T cells. The ...

Program business did not explode because of luck or timing; it grew because an underserved yet powerful corner of the market ...

Private equity used to be reserved for endowments and sovereign wealth funds. Now you can buy it on your phone. Publicly ...

Tevogen Bio, the company’s lead initiative, has completed a proof-of-concept clinical trial demonstrating the potential of its single-HLA-restricted, genetically unmodified allogeneic T cells. Tevogen ...

Willis said its eight-point model is designed to address the full risk cycle. The framework is explicitly structured around balance-sheet protection and capital alignment. The company said the new ...

Two key players in the consumer finance space that target the underserved credit segments, such as subprime and non-prime borrowers, are Pagaya Technologies Ltd. PGY and OneMain Holdings, Inc. OMF.

Stifel Financial Corp. (NYSE:SF) Q4 2025 Earnings Call Transcript January 28, 2026 Stifel Financial Corp. misses on earnings ...

The facility was inaugurated in a ceremony attended by Khalifa Al Masaood, Director at Al Masaood Group; Irfan Tansel, Chief Executive Officer of Al Masaood Automobiles; Massimiliano Messina, ...

Ooops... Something went wrong while loading this page.

Tevogen ("Tevogen Bio Holdings Inc." or "Company") (Nasdaq: TVGN) today announced that its Board of Directors has expressed its intention to evaluate the ...